The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer and the leading cause of cancer mortality. Several lines of evidence have demonstrated the aberrant expression of long noncoding RNAs (lncRNAs) in carcinogenesis and their universal regulatory properties. A thorough understanding o...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253120300998 |
id |
doaj-da9b1332c6094dfda32e8afc505f995a |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xi Lan Nan Wu Litao Wu Kai Qu Ezra Kombo Osoro Dongxian Guan Xiaojuan Du Bo Wang Sifan Chen Ji Miao Juan Ren Li Liu Haiyun Li Qilan Ning Dongmin Li Shemin Lu |
spellingShingle |
Xi Lan Nan Wu Litao Wu Kai Qu Ezra Kombo Osoro Dongxian Guan Xiaojuan Du Bo Wang Sifan Chen Ji Miao Juan Ren Li Liu Haiyun Li Qilan Ning Dongmin Li Shemin Lu The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p Molecular Therapy: Nucleic Acids LNC-HC hsa-miR-183-5p hepatocellular carcinoma molecular mechanism |
author_facet |
Xi Lan Nan Wu Litao Wu Kai Qu Ezra Kombo Osoro Dongxian Guan Xiaojuan Du Bo Wang Sifan Chen Ji Miao Juan Ren Li Liu Haiyun Li Qilan Ning Dongmin Li Shemin Lu |
author_sort |
Xi Lan |
title |
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p |
title_short |
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p |
title_full |
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p |
title_fullStr |
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p |
title_full_unstemmed |
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p |
title_sort |
human novel gene lnc-hc inhibits hepatocellular carcinoma cell proliferation by sequestering hsa-mir-183-5p |
publisher |
Elsevier |
series |
Molecular Therapy: Nucleic Acids |
issn |
2162-2531 |
publishDate |
2020-06-01 |
description |
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer and the leading cause of cancer mortality. Several lines of evidence have demonstrated the aberrant expression of long noncoding RNAs (lncRNAs) in carcinogenesis and their universal regulatory properties. A thorough understanding of lncRNA regulatory roles in HCC pathology would contribute to HCC prevention and treatment. In this study, we identified a novel human lncRNA, LNC-HC, with significantly reduced levels in hepatic tumors from patients with HCC. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide) assays as well as colony formation and wound healing experiments showed that LNC-HC significantly inhibited the proliferation of the HCC cell line Huh7. Xenograft transplantation of LNC-HC-overexpressing Huh7 cells in nude mice resulted in the production of smaller tumors. Mechanistically, LNC-HC inhibited the proliferation of HCC cells by directly interacting with hsa-miR-183-5p. LNC-HC rescued the expression of five tumor suppressors, including AKAP12, DYRK2, FOXN3, FOXO1, and LATS2, that were verified as target genes of hsa-miR-183-5p. Overall, human LNC-HC was identified as a novel tumor suppressor that could inhibit HCC cell proliferation in vitro and suppress tumor growth in vivo by competitively binding hsa-miR-183-5p as a competing endogenous RNA (ceRNA). These findings suggest that LNC-HC could be a biomarker of HCC and provide a novel therapeutic target for HCC treatment. |
topic |
LNC-HC hsa-miR-183-5p hepatocellular carcinoma molecular mechanism |
url |
http://www.sciencedirect.com/science/article/pii/S2162253120300998 |
work_keys_str_mv |
AT xilan thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT nanwu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT litaowu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT kaiqu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT ezrakomboosoro thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT dongxianguan thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT xiaojuandu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT bowang thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT sifanchen thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT jimiao thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT juanren thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT liliu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT haiyunli thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT qilanning thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT dongminli thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT sheminlu thehumannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT xilan humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT nanwu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT litaowu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT kaiqu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT ezrakomboosoro humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT dongxianguan humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT xiaojuandu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT bowang humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT sifanchen humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT jimiao humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT juanren humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT liliu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT haiyunli humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT qilanning humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT dongminli humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p AT sheminlu humannovelgenelnchcinhibitshepatocellularcarcinomacellproliferationbysequesteringhsamir1835p |
_version_ |
1724628709760040960 |
spelling |
doaj-da9b1332c6094dfda32e8afc505f995a2020-11-25T03:18:08ZengElsevierMolecular Therapy: Nucleic Acids2162-25312020-06-0120468479The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5pXi Lan0Nan Wu1Litao Wu2Kai Qu3Ezra Kombo Osoro4Dongxian Guan5Xiaojuan Du6Bo Wang7Sifan Chen8Ji Miao9Juan Ren10Li Liu11Haiyun Li12Qilan Ning13Dongmin Li14Shemin Lu15Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, China; Corresponding author: Xi Lan, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDivision of Endocrinology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USADepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaCenter for Translational Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Shaanxi 710061, ChinaMedical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, ChinaDivision of Endocrinology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USADepartment of Reproductive Medicine, The Fourth Hospital of Xi’an, Xi’an, Shaanxi 710004, ChinaDepartment of Basic Medical Science, Xi’an Medical College, Xi’an, Shaanxi, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory of the Environment and Genes Related to Diseases, Xi’an Jiaotong University, Ministry of Education of China, Beijing, China; Corresponding author: Shemin Lu, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer and the leading cause of cancer mortality. Several lines of evidence have demonstrated the aberrant expression of long noncoding RNAs (lncRNAs) in carcinogenesis and their universal regulatory properties. A thorough understanding of lncRNA regulatory roles in HCC pathology would contribute to HCC prevention and treatment. In this study, we identified a novel human lncRNA, LNC-HC, with significantly reduced levels in hepatic tumors from patients with HCC. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium bromide) assays as well as colony formation and wound healing experiments showed that LNC-HC significantly inhibited the proliferation of the HCC cell line Huh7. Xenograft transplantation of LNC-HC-overexpressing Huh7 cells in nude mice resulted in the production of smaller tumors. Mechanistically, LNC-HC inhibited the proliferation of HCC cells by directly interacting with hsa-miR-183-5p. LNC-HC rescued the expression of five tumor suppressors, including AKAP12, DYRK2, FOXN3, FOXO1, and LATS2, that were verified as target genes of hsa-miR-183-5p. Overall, human LNC-HC was identified as a novel tumor suppressor that could inhibit HCC cell proliferation in vitro and suppress tumor growth in vivo by competitively binding hsa-miR-183-5p as a competing endogenous RNA (ceRNA). These findings suggest that LNC-HC could be a biomarker of HCC and provide a novel therapeutic target for HCC treatment.http://www.sciencedirect.com/science/article/pii/S2162253120300998LNC-HChsa-miR-183-5phepatocellular carcinomamolecular mechanism |